BiomX
Shachar Haran started working as a Commodities Trader at GHF Group in 2009 and held the position until 2010. In 2010, they joined the Office of the Prime Minister of Israel in an Operations role, where they worked until their next position. In 2018, Shachar Haran became a Quality Control Analyst at Teva Pharmaceuticals, staying in that role until 2021. Currently, they are employed as a QC Scientist at BiomX Inc, starting in March 2021.
Shachar Haran attended Tel Aviv University from 2013 to 2017, where they obtained a Bachelor's degree in Biology and Philosophy.
This person is not in any offices
BiomX
BiomX is developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as cystic fibrosis, inflammatory bowel disease, atopic dermatitis, and colorectal cancer.